|
1
|
Bron AJ, Benjamin L and Snibson GR:
Meibomian gland disease. Classification and grading of lid changes.
Eye (Lond). 5:395–411. 1991.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lekhanont K, Rojanaporn D, Chuck RS and
Vongthongsri A: Prevalence of dry eye in Bangkok, Thailand. Cornea.
25:1162–1167. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P
and Hsu WM: Prevalence of dry eye among an elderly Chinese
population in Taiwan: The Shihpai Eye Study. Ophthalmology.
110:1096–1101. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Uchino M, Dogru M, Yagi Y, Goto E, Tomita
M, Kon T, Saiki M, Matsumoto Y, Uchino Y, Yokoi N, et al: The
features of dry eye disease in a Japanese elderly population. Optom
Vis Sci. 83:797–802. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jie Y, Xu L, Wu YY and Jonas JB:
Prevalence of dry eye among adult Chinese in the Beijing Eye Study.
Eye (Lond). 23:688–693. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tomlinson A, Bron AJ, Korb DR, Amano S,
Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R and Dogru M: The
international workshop on meibomian gland dysfunction: Report of
the diagnosis subcommittee. Invest Ophthalmol Vis Sci.
52:2006–2049. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dougherty JM, McCulley JP, Silvany RE and
Meyer DR: The role of tetracycline in chronic blepharitis.
Inhibition of lipase production in staphylococci. Invest Ophthalmol
Vis Sci. 32:2970–2975. 1991.PubMed/NCBI
|
|
8
|
Tabbara KF, al-Kharashi SA, al-Mansouri
SM, al-Omar OM, Cooper H, el-Asrar AM and Foulds G: Ocular levels
of azithromycin. Arch Ophthalmol. 116:1625–1628. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schultz C: Safety and efficacy of
cyclosporine in the treatment of chronic dry eye. Ophthalmol Eye
Dis. 6:37–42. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ma X and Lu Y: Efficacy of intraductal
meibomian gland probing on tear function in patients with
obstructive meibomian gland dysfunction. Cornea. 35:725–730.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sik Sarman Z, Cucen B, Yuksel N, Cengiz A
and Caglar Y: Effectiveness of intraductal meibomian gland probing
for obstructive meibomian gland dysfunction. Cornea. 35:721–724.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gumus K, Schuetzle KL and Pflugfelder SC:
Randomized controlled crossover trial comparing the impact of sham
or intranasal tear neurostimulation on conjunctival goblet cell
degranulation. Am J Ophthalmol. 177:159–168. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Raulin C, Greve B and Grema H: IPL
technology: A review. Lasers Surg Med. 32:78–87. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Babilas P, Schreml S, Szeimies R-M and
Landthaler M: Intense pulsed light (IPL): A review. Lasers Surg
Med. 42:93–104. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schuh A, Priglinger S and Messmer EM:
Intense pulsed light (IPL) as a therapeutic option for Meibomian
gland dysfunction. Ophthalmologe. 116:982–988. 2019.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
16
|
Brinton M, Kossler AL, Patel ZM, Loudin J,
Franke M, Ta CN and Palanker D: Enhanced tearing by electrical
stimulation of the anterior ethmoid nerve. Invest Ophthalmol Vis
Sci. 58:2341–2348. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Toyos R, McGill W and Briscoe D: Intense
pulsed light treatment for dry eye disease due to meibomian gland
dysfunction; a 3-year retrospective study. Photomed Laser Surg.
33:41–46. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dell SJ, Gaster RN, Barbarino SC and
Cunningham DN: Prospective evaluation of intense pulsed light and
meibomian gland expression efficacy on relieving signs and symptoms
of dry eye disease due to meibomian gland dysfunction. Clin
Ophthalmol. 11:817–827. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Goldberg DJ: Current trends in intense
pulsed light. J Clin Aesthet Dermatol. 5:45–53. 2012.PubMed/NCBI
|
|
20
|
Craig JP, Chen YH and Turnbull PR:
Prospective trial of intense pulsed light for the treatment of
meibomian gland dysfunction. Invest Ophthalmol Vis Sci.
56:1965–1970. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Arita R, Mizoguchi T, Fukuoka S and
Morishige N: Multicenter study of intense pulsed light therapy for
patients with refractory meibomian gland dysfunction. Cornea.
37:1566–1571. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Arita R, Mizoguchi T, Fukuoka S and
Morishige N: Therapeutic efficacy of intense pulsed light in
patients with refractory meibomian gland dysfunction. Ocul Surf.
17:104–110. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yin Y, Liu N, Gong L and Song N: Changes
in the meibomian gland after exposure to intense pulsed light in
meibomian gland dysfunction (MGD) patients. Curr Eye Res.
43:308–313. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rong B, Tang Y, Tu P, Liu R, Qiao J, Song
W, Toyos R and Yan X: Intense pulsed light applied directly on
eyelids combined with meibomian gland expression to treat meibomian
gland dysfunction. Photomed Laser Surg. 36:326–332. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rong B, Tang Y, Liu R, Tu P, Qiao J, Song
W and Yan X: Long-term effects of intense pulsed light combined
with meibomian gland expression in the treatment of meibomian gland
dysfunction. Photomed Laser Surg. 36:562–567. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jiang X, Lv H, Song H, Zhang M, Liu Y, Hu
X, Li X and Wang W: Evaluation of the safety and effectiveness of
intense pulsed light in the treatment of meibomian gland
dysfunction. J Ophthalmol. 2016(1910694)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gupta PK, Vora GK, Matossian C, Kim M and
Stinnett S: Outcomes of intense pulsed light therapy for treatment
of evaporative dry eye disease. Can J Ophthalmol. 51:249–253.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vegunta S, Patel D and Shen JF:
Combination therapy of intense pulsed light therapy and meibomian
gland expression (IPL/MGX) can improve dry eye symptoms and
meibomian gland function in patients with refractory dry eye: A
retrospective analysis. Cornea. 35:318–322. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Karaca EE, Evren Kemer Ö and Özek D:
Intense regulated pulse light for the meibomian gland dysfunction.
Eur J Ophthalmol. 30:289–292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Seo KY, Kang SM, Ha DY, Chin HS and Jung
JW: Long-term effects of intense pulsed light treatment on the
ocular surface in patients with rosacea-associated meibomian gland
dysfunction. Cont Lens Anterior Eye. 41:430–435. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Toyos R, Toyos M, Willcox J, Mulliniks H
and Hoover J: Evaluation of the safety and efficacy of intense
pulsed light treatment with meibomian gland expression of the upper
eyelids for dry eye disease. Photobiomodul Photomed Laser Surg.
37:527–531. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Moher D, Shamseer L, Clarke M, Ghersi D,
Liberati A, Petticrew M, Shekelle P and Stewart LA: PRISMA-P Group.
Preferred reporting items for systematic review and meta-analysis
protocols (PRISMA-P) 2015 statement. Syst Rev. 4(1)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Higgins J and Green S: Cochrane Handbook
for systemic reviews of interventions. Version 5.1: The Cochrane
Collaboration, 2011. https://handbook-5-1.cochrane.org.
Accessed July 1, 2019.
|
|
34
|
Vora GK and Gupta PK: Intense pulsed light
therapy for the treatment of evaporative dry eye disease. Curr Opin
Ophthalmol. 26:314–318. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Albietz JM and Schmid KL: Intense pulsed
light treatment and meibomian gland expression for moderate to
advanced meibomian gland dysfunction. Clin Exp Optom. 101:23–33.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ngo W, SItu P, Keir N, Korb D, Blackie C
and Simpson T: Psychometric properties and validation of the
standard patient evaluation of eye dryness questionnaire. Cornea.
32:1204–1210. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vidas Pauk S, Petriček I, Jukić T,
Popović-Suić S, Tomić M, Kalauz M, Jandroković S and Masnec S:
Noninvasive tear film break-up time assessment using handheld lipid
layer examination instrument. Acta Clin Croat. 58:63–71.
2019.PubMed/NCBI View Article : Google Scholar
|
